ketamine has been researched along with Tachycardia, Ventricular in 6 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have investigated the effects of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate (MK801), a non-competitive N-methyl-D-aspartate (NMDA) ionotropic excitatory amino acid receptor antagonist, and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), a non-NMDA ionotropic excitatory amino acid receptor antagonist, ketamine and memantine, NMDA receptor channel blockers, on ventricular arrhythmias induced by myocardial ischaemia and myocardial ischaemia-reperfusion." | 3.70 | Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists. ( D'Amico, M; Di Filippo, C; Rossi, F, 1999) |
| "Anesthesia sometimes suppresses ventricular tachyarrhythmias (VT) resistant to conventional pharmacological treatment." | 1.37 | Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome. ( Ajiki, K; Hayami, N; Inaba, H; Kunishima, T; Mikamo, T; Murakawa, Y; Sugiura, A; Tsutsui, K; Watanabe, H; Yamagishi, N; Yamagishi, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, CC | 1 |
| Chen, CK | 1 |
| Smollin, CG | 1 |
| Yu, JH | 1 |
| Seak, CJ | 1 |
| Chen, HY | 1 |
| Stukus, KS | 1 |
| Przybylowicz, RW | 1 |
| Backes, CH | 1 |
| Cohen, DM | 1 |
| Marzuillo, P | 1 |
| Rabach, I | 1 |
| Barbi, E | 1 |
| Atiyeh, RH | 1 |
| Arthur, ME | 1 |
| Berman, AE | 1 |
| Castresana, MR | 1 |
| Inaba, H | 1 |
| Hayami, N | 1 |
| Ajiki, K | 1 |
| Kunishima, T | 1 |
| Watanabe, H | 1 |
| Tsutsui, K | 1 |
| Yamagishi, N | 1 |
| Yamagishi, S | 1 |
| Sugiura, A | 1 |
| Mikamo, T | 1 |
| Murakawa, Y | 1 |
| D'Amico, M | 1 |
| Di Filippo, C | 1 |
| Rossi, F | 2 |
6 other studies available for ketamine and Tachycardia, Ventricular
| Article | Year |
|---|---|
Pulseless ventricular tachycardia associated with chronic ketamine use.
Topics: Adult; Female; Humans; Ketamine; Tachycardia, Ventricular; Taiwan; Treatment Outcome | 2017 |
Ventricular tachycardia after ketamine sedation for fracture reduction.
Topics: Anesthetics, Dissociative; Child; Conscious Sedation; Female; Humans; Ketamine; Radius Fractures; Ta | 2014 |
Ondasetron Is More Likely Than Ketamine to Cause Ventricular Tachycardia.
Topics: Anesthetics, Dissociative; Female; Humans; Ketamine; Tachycardia, Ventricular | 2015 |
The utility of ketamine in facilitating the induction of isoproterenol-refractory idiopathic ventricular tachyarrhythmias.
Topics: Drug Synergism; Electrocardiography; Female; Humans; Isoproterenol; Ketamine; Tachycardia, Ventricul | 2009 |
Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome.
Topics: Adrenergic alpha-2 Receptor Agonists; Anesthesia, General; Anesthetics, Combined; Animals; Anti-Arrh | 2011 |
Arrhythmias induced by myocardial ischaemia-reperfusion are sensitive to ionotropic excitatory amino acid receptor antagonists.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arrhythmias, Cardiac; Blood Pressure; Dizocilpine Mal | 1999 |